Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg (Q21004071)
Jump to navigation
Jump to search
scientific article published in 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg |
scientific article published in 2007 |
Statements
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg (English)
0 references
Carla E M
Hollak
Carla E M Hollak
2 references
Gabor E
Linthorst
Gabor E Linthorst
2 references
Johannes M F G
Aerts
Johannes M F G Aerts
2 references
Anouk C Vedder
2 references
Gunnar Houge
2 references
Johannna E M Groener
2 references
Els E Ormel
2 references
Berto J Bouma
2 references
Asle Hirth
2 references
2007
0 references
2
0 references
7
0 references
e598
0 references
11 July 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference